Peripheral CD4+ T‐Cell Reserve as a Potential Biomarker of CD20 × CD3 Bispecific Antibody Outcomes and BTK Inhibitor–Associated Immune Modulation in B‐Cell Lymphoma
Hui Yu,
Jin Chai,
Jiaowu Cao,
Dingyao Hu,
Zhao Jin,
Yanxiang Li,
Jie Lv,
Jie Chen,
Yue Wang,
Wenhui Zhang,
Jun Zhu,
Yuqin Song
Wiley ·
2026-10-10
· DOI 10.1002/hon.70266
⬢ Cited by: 0Crossref
The publisher did not provide an abstract — full text is available via the link below.
Hui Yu, Jin Chai, Jiaowu Cao, Dingyao Hu, Zhao Jin, Yanxiang Li et al. Peripheral CD4+ T‐Cell Reserve as a Potential Biomarker of CD20 × CD3 Bispecific Antibody Outcomes and BTK Inhibitor–Associated Immune Modulation in B‐Cell Lymphoma. // Hematological Oncology. – 2026. – DOI: 10.1002/hon.70266. – URL: https://onlinelibrary.wiley.com/doi/10.1002/hon.70266?af=R
Hui Yu, Jin Chai, Jiaowu Cao, Dingyao Hu, Zhao Jin, Yanxiang Li, Jie Lv, Jie Chen, Yue Wang, Wenhui Zhang, Jun Zhu, & Yuqin Song (2026). Peripheral CD4+ T‐Cell Reserve as a Potential Biomarker of CD20 × CD3 Bispecific Antibody Outcomes and BTK Inhibitor–Associated Immune Modulation in B‐Cell Lymphoma. Hematological Oncology. https://doi.org/10.1002/hon.70266
Hui Yu, et al. “Peripheral CD4+ T‐Cell Reserve as a Potential Biomarker of CD20 × CD3 Bispecific Antibody Outcomes and BTK Inhibitor–Associated Immune Modulation in B‐Cell Lymphoma.” Hematological Oncology, 2026. doi:10.1002/hon.70266.
@article{Yu2026,
title = {Peripheral CD4+ T‐Cell Reserve as a Potential Biomarker of CD20 × CD3 Bispecific Antibody Outcomes and BTK Inhibitor–Associated Immune Modulation in B‐Cell Lymphoma},
author = {Yu, Hui and Chai, Jin and Cao, Jiaowu and Hu, Dingyao and Jin, Zhao and Li, Yanxiang and Lv, Jie and Chen, Jie and Wang, Yue and Zhang, Wenhui and Zhu, Jun and Song, Yuqin},
journal = {Hematological Oncology},
year = {2026},
doi = {10.1002/hon.70266},
url = {https://onlinelibrary.wiley.com/doi/10.1002/hon.70266?af=R}
}